A study of workers' compensation drug prescription costs by The Hartford has found evidence that narcotic pharmaceuticals continue to be overprescribed, according to an executive with the company.
Dr. Rob Bonner, medical director for The Hartford, said the findings were especially surprising "given there have been several evidence-based treatment guidelines published over the past several years that recommend very limited use of narcotics for musculo-skeletal conditions."
About 40 percent of The Hartford's spending on workers' comp pharmaceutical claims is for narcotics, he said.
Recommended For You
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more inforrmation visit Asset & Logo Licensing.
